InsiderSignal.AI

InsiderSignal.ai

KALV - Kalvista Pharmaceuticals, Inc.

Insider Sale by Audhya Paul K. (CHIEF MEDICAL OFFICER)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Audhya Paul K., serving as CHIEF MEDICAL OFFICER at Kalvista Pharmaceuticals, Inc. (KALV), sold 2,686 shares at $20.22 per share, for a total transaction value of $54,301.00. Following this transaction, Audhya Paul K. now holds 142,547 shares of KALV.

This sale represents a 2.00% decrease in Audhya Paul K.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, April 17, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 20, 2026, 3 days after the trade was made.

Kalvista Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Audhya Paul K.

CHIEF MEDICAL OFFICER

Paul K. Audhya, MD, MBA is the Chief Medical Officer at KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a role he currently holds.[[3]](https://www.emedevents.com/speaker-profile/paul-audhya)[[5]](https://www.kalvista.com/about/senior-management/) In this position, he oversees medical affairs and strategy for the company, which focuses on developing oral plasma kallikrein inhibitors for hereditary angioedema treatments.[[5]](https://www.kalvista.com/about/senior-management/) Audhya previously served as VP of Global Strategy & Medical Affairs, bringing expertise in internal medicine from Cambridge, Massachusetts.[[3]](https://www.emedevents.com/speaker-profile/paul-audhya) He is board-certified in internal medicine and holds an MD and MBA.[[3]](https://www.emedevents.com/speaker-profile/paul-audhya)[[5]](https://www.kalvista.com/about/senior-management/) Recently, on February 23, 2026, he sold 5,354 shares of KALV stock for approximately $83,000 as part of a tax-related 'sell-to-cover' transaction following RSU vesting, retaining 138,983 shares directly.[[1]](https://www.investing.com/news/insider-trading-news/kalvista-pharma-cmo-audhya-sells-83k-in-shares-93CH-4523128)[[2]](https://www.moomoo.com/news/post/65988801/insider-sale-chief-medical-officer-of-kalv-sells-5354-shares)[[4]](https://www.stocktitan.net/sec-filings/KALV/form-4-kal-vista-pharmaceuticals-inc-insider-trading-activity-cf55c79ac88e.html)

View full insider profile →

Trade Price

$20.22

Quantity

2,686

Total Value

$54,301.00

Shares Owned

142,547

Trade Date

Friday, April 17, 2026

4 days ago

SEC Filing Date

Monday, April 20, 2026

Filed 3 days after trade

HEALTHCAREBIOTECHNOLOGY

About Kalvista Pharmaceuticals, Inc.

Company Overview

No company information available
View news mentioning KALV

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5810444

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime